SS Innovations International, Inc.

SSII ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $13.9M $11.1M $14.5M $12.8M $10.0M $5.1M $8.1M $4.4M
Cost of Revenue $6.8M $5.8M $8.2M $6.7M $4.1M $4.0M $4.1M $2.1M
Gross Profit $7.1M $5.3M $6.4M $6.2M $5.9M $1.1M $4.0M $2.3M
Gross Margin 50.9% 48.0% 43.9% 48.1% 59.1% 21.2% 48.9% 52.8%
Operating Expenses
Research & Development $2.4M $995.4K $1.4M $786.3K $498.6K $1.0M $761.9K $442.8K
SG&A Expense $4.5M $4.5M $3.2M $4.8M $3.4M $3.4M $2.6M $2.5M
Operating Income $-2.3M $-3.6M $-533.9K $-1.8M $97.0K $-5.9M $-1.8M $-3.2M
Operating Margin -16.3% -32.8% -3.7% -14.3% 1.0% -115.6% -22.7% -73.1%
Interest Expense — $43.6K — — — $155.0K — —
Pretax Income $-2.2M $-3.4M $-705.7K $-1.9M $97.0K $-5.7M $-1.9M $-3.2M
Income Tax Expense $505.3K $151.4K — $1.8M $353.7K — — —
Net Income $-2.7M $-3.6M $-2.5M $-3.7M $-256.7K $-5.7M $-1.9M $-3.2M
Net Margin -19.1% -32.3% -17.0% -29.0% -2.6% -111.0% -23.7% -74.0%
EPS (Basic) $-0.01 $-0.02 $-0.01 $-0.02 $0.00 $-0.03 $-0.01 $-0.02
EPS (Diluted) $-0.01 $-0.02 $-0.01 $-0.02 $0.00 $-0.03 $-0.01 $-0.02
Shares Outstanding (Basic) 200.1M 196.0M 190.0M 193.6M 193.6M 178.8M 170.8M 170.8M
Shares Outstanding (Diluted) 209.4M 205.3M 198.7M 202.9M 202.8M 188.6M 181.2M 181.9M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →